List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 45 studies with search of:   "Gemtuzumab"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin in CBF Leukemias
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim (Neupogen, G-CSF);   Drug: Gemtuzumab Ozogamicin
2 Recruiting Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Mitoxantrone;   Drug: Etoposide
3 Recruiting All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab and Theophylline
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: All-Trans Retinoic Acid;   Drug: Arsenic Trioxide;   Drug: Gemtuzumab Ozogamicin;   Drug: Theophylline
4 Recruiting Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: filgrastim;   Drug: gemtuzumab ozogamicin;   Drug: sargramostim;   Procedure: observation
5 Completed Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
Condition: Acute Myelogenous Leukemia
Intervention: Drug: Mylotarg (gemtuzumab ozogamicin) Injection
6 Active, not recruiting Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Cytarabine;   Drug: Mitoxantrone;   Drug: Gemtuzumab Ozogamicin;   Drug: All-trans-Retinoid Acid
7 Completed A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Condition: Leukemia, Myeloid
Interventions: Drug: Zosuquidar;   Drug: gemtuzumab ozogamicin
8 Active, not recruiting Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: gemtuzumab ozogamicin
9 Active, not recruiting Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Mylotarg;   Drug: Cytarabine
10 Active, not recruiting Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: idarubicin;   Drug: mitoxantrone hydrochloride
11 Active, not recruiting Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: gemtuzumab ozogamicin
12 Completed Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cyclosporine;   Drug: gemtuzumab ozogamicin
13 Active, not recruiting Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: gemtuzumab ozogamicin;   Drug: oblimersen
14 Recruiting Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: gemtuzumab ozogamicin
15 Recruiting Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: mitoxantrone hydrochloride
16 Recruiting Vorinostat and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: gemtuzumab ozogamicin;   Drug: vorinostat
17 Completed Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
Condition: Acute Myeloid Leukemia
Intervention: Drug: Mylotarg
18 Active, not recruiting Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Leukemia
Intervention: Drug: gemtuzumab ozogamicin
19 Recruiting Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Drug: arsenic trioxide;   Drug: gemtuzumab ozogamicin;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: tretinoin
20 Active, not recruiting Gemtuzumab Ozogamicin, Fludarabine, and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services